Core Points - Shuyou Shen (300204) reported a closing price of 34.13 yuan on October 27, 2025, with a market capitalization of 16.306 billion yuan, reflecting a 0.47% increase from the previous trading day [1] - The company announced a plan to issue shares to specific investors, aiming to raise no more than 1.253 billion yuan for innovative drug research and to supplement working capital [1] - The share issuance will not exceed 30% of the total share capital prior to issuance, amounting to 143,331,766 shares, and has been approved by the board and shareholders, pending review by the Shenzhen Stock Exchange and registration with the CSRC [1] Financial Details - The funds raised will allocate 883 million yuan for clinical research and registration of innovative drugs BDB-001, STSA-1002, and STSP-0902, while 370 million yuan will be used to supplement working capital [1] - The issuance will not result in a change of control for the company and does not constitute a major asset restructuring [1] Risk Factors - The company has indicated potential risks including performance losses and the possibility that fundraising projects may not meet expectations [1]
舒泰神(300204)披露向特定对象发行股票募集说明书,10月27日股价上涨0.47%